Statins, diabetes, obesity, nonalcoholic fatty liver disease, and hepatocellular carcinoma.
作者信息
Han Jun, Yan Wen-Tao, Quan Bing, Wang Ming-Da, Yang Tian
机构信息
Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, the Second Military Medical University, (No. 225) Changhai Road, Shanghai 200438, China.
Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, the Second Military Medical University, (No. 225) Changhai Road, Shanghai 200438, China; Department of Clinical Medicine, the Second Military Medical University, No.800 Xiangyin Road, Shanghai 200433, China.
出版信息
Hepatobiliary Pancreat Dis Int. 2019 Apr;18(2):202. doi: 10.1016/j.hbpd.2018.10.004. Epub 2018 Nov 16.
PMID:30473472
Abstract
摘要
相似文献
1
Statins, diabetes, obesity, nonalcoholic fatty liver disease, and hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int. 2019 Apr;18(2):202. doi: 10.1016/j.hbpd.2018.10.004. Epub 2018 Nov 16.
2
Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases.
Clin Mol Hepatol. 2022 Oct;28(4):773-789. doi: 10.3350/cmh.2021.0383. Epub 2022 Aug 8.
3
Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma.
Clin Liver Dis. 2015 May;19(2):361-79. doi: 10.1016/j.cld.2015.01.012. Epub 2015 Mar 12.
4
Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
Clin Liver Dis. 2018 Feb;22(1):201-211. doi: 10.1016/j.cld.2017.08.014.
5
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
World J Gastroenterol. 2015 Apr 14;21(14):4103-10. doi: 10.3748/wjg.v21.i14.4103.
6
Letter to the Editor: The Association Between Diabetes and Hepatocellular Carcinoma in Patients With Cirrhosis Caused by Nonalcoholic Fatty Liver Disease.
Hepatology. 2020 Jul;72(1):363-364. doi: 10.1002/hep.31099.
7
[Prevalence and harm of nonalcoholic fatty liver disease].
Zhonghua Gan Zang Bing Za Zhi. 2019 Jan 20;27(1):10-13. doi: 10.3760/cma.j.issn.1007-3418.2019.01.004.
8
[Advances in diagnosis and treatment of nonalcoholic fatty liver disease].
Zhonghua Gan Zang Bing Za Zhi. 2016 Feb;24(2):81-4. doi: 10.3760/cma.j.issn.1007-3418.2016.02.001.
9
The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease.
Int J Cancer. 2017 Oct 1;141(7):1307-1314. doi: 10.1002/ijc.30784. Epub 2017 Jun 30.
10
Are statins 'IDEAL' for non-alcoholic fatty liver disease?
Curr Med Res Opin. 2014 Feb;30(2):229-31. doi: 10.1185/03007995.2013.855192. Epub 2013 Oct 28.
Zotero 插件